125 results
6-K
EX-99.1
ALVO
Alvotech
21 May 24
Current report (foreign)
8:41am
medicines. Driven by our purpose of ‘Good Health Can’t Wait’, we offer a portfolio of products and services including APIs, generics, branded generics
6-K
EX-99.1
ALVO
Alvotech
16 Apr 24
Current report (foreign)
6:30pm
of SELARSDI leveraged our purpose-built end-to-end development and manufacturing platform for biosimilars. Being able to develop the biosimilar
6-K
EX-99.2
ALVO
Alvotech
20 Mar 24
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
4:30pm
(“Alvotech” or the “Company”). Alvotech was incorporated on August 23, 2021 for the sole purpose of completing a business combination between
6-K
EX-99.3
o6kr 6mh7
20 Mar 24
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
4:30pm
F-3
EX-4.5
meqpce zhu26q7
20 Oct 23
Shelf registration (foreign)
4:06pm
F-3
3574qpq37l
20 Oct 23
Shelf registration (foreign)
4:06pm
F-3
EX-5.1
0etf3
20 Oct 23
Shelf registration (foreign)
4:06pm
6-K/A
EX-99.1
tnnq60mni 0avz5we
7 Sep 23
Current report (foreign) (amended)
1:06pm
6-K
EX-99.2
vodxep8j2ntospcbt
31 Aug 23
Current report (foreign)
8:00am
6-K
EX-99.3
zqn9ld8mivylbf 5zpl
31 Aug 23
Current report (foreign)
8:00am
6-K
EX-99.5
h0z5il8rqac 7q
31 Aug 23
Current report (foreign)
8:00am
6-K
EX-99.1
a8pvq
31 Aug 23
Current report (foreign)
8:00am
6-K
EX-99.6
xhrxnc5 xxr
31 Aug 23
Current report (foreign)
8:00am
6-K
EX-5.1
wsvdj9ujq6
24 Jul 23
Provide Update on Strategic Biosimilars Partnership
4:15pm
424B3
sh1p5if
24 Jul 23
Prospectus supplement
8:03am
424B3
0n80s1
24 Jul 23
Prospectus supplement
8:00am
F-3
k1zdl 6c6
14 Jul 23
Shelf registration (foreign)
4:56pm
F-3
EX-5.1
625u6ajlijqtakr
14 Jul 23
Shelf registration (foreign)
4:56pm